Evidence map›Paper›PMID 37494393›Full record

SynthesisPloS one2023

Global depression in breast cancer patients: Systematic review and meta-analysis.

Akbar Javan Biparva, Samira Raoofi, Sima Rafiei, Maryam Masoumi, Maryam Doustmehraban, Farzaneh Bagheribayati, Elahe Sadat Vaziri Shahrebabak, Zahra Noorani Mejareh, Saghar Khani, Bahare Abdollahi and 7 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 9 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 9 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Efficacy and safety of modifiedFrontiers in pharmacology · 2026
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Akbar Javan BiparvaStudent Research Committee, School of Health Management and Medical Informatics, Iranian Center of Excellence in Health Management, Tabriz University of Medical Sciences, Tabriz, Iran.
Samira RaoofiDepartment of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Sima RafieiSocial Determinants of Health Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.
Maryam MasoumiClinical Research and Development Center, Qom University of Medical Sciences, Qom, Iran.
Maryam DoustmehrabanSocial Determinants of Health Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Farzaneh BagheribayatiCellular and Molecular Biology, University of Zanjan, Zanjan, Iran.
Elahe Sadat Vaziri ShahrebabakStudent Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Zahra Noorani MejarehStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Saghar KhaniStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Bahare AbdollahiStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Zahra Abedi BafrajardStudent Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Shakila Sotoude BeidokhtiStudent Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Seyedeh Fahimeh ShojaeiFiroozgar Clinical Research and Development Center (FCRDC), Iran University of Medical Sciences, Tehran, Iran.
Mahdieh RastegarStudent Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Fatemeh Pashazadeh KanStudent Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Elmira Nosrati SanjabadStudent Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Ahmad GhashghaeeThe School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0002-3607-666X
Iran University of Medical Sciences · IRQazvin University of Medical Sciences · IRQom University of Medical Science and Health Services · IRTabriz University of Medical Sciences · IRUniversity of Glasgow · GBUniversity of Zanjan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is known as one of the most common diseases among women, the psychological consequences of which are common in women and affect various aspects of their lives, so this study aims to investigate the prevalence of depression among women with breast cancer globally.

methodThe present meta-analysis was performed by searching for keywords related to breast cancer and depression in 4 main databases: PubMed, Embase, Web of Sciences and Scopus in the period of January 2000 to November 2021 and the results of the study using R and CMA software were analyzed.

resultsA total of 71 studies were selected in English and the results of the analysis showed that the prevalence of depression in women with breast cancer is 30.2%, with Pakistan having the highest (83%) prevalence of depression and Taiwan having the lowest (8.3%). And in the WHO regions, EMRO region had the highest (49.7%) rate and SEARO region had the lowest (23%) prevalence of depression. Also, with increasing age, the prevalence of depression among women with breast cancer increases.

conclusionCommunity and family support for women with breast cancer, holding psychology and psychotherapy courses, lifestyle modifications and training in this area can be effective in preventing the reduction of the prevalence of depression, and given the pivotal role of women in family affairs, this This can be in line with the work of health system policymakers.

Indexed as

Breast NeoplasmsDepressionFamily SupportFemaleHumansPrevalencePsychotherapy

Identifiers

PMID37494393
PMCPMC10370744
OpenAlexW4385288338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.